Close Menu

NEW YORK – LifeSpan BioSciences said this week that it has acquired Everest Biotech, which specializes in the production of antigen affinity purified goat polyclonal antibodies. The acquisition will expand LSBio's offering of more than 500,000 monoclonal and polyclonal primary antibodies, the company said. Financial terms of the acquisition were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.